Wasney M, Briscoe L, Wolff R, Ghezzi H, Tropini C, Garud N
bioRxiv. 2025; .
PMID: 39974986
PMC: 11838389.
DOI: 10.1101/2025.01.28.635365.
Chen Y, Fang H, Chen H, Liu X, Zhao J, Stanton C
Gut Microbes. 2025; 17(1):2464945.
PMID: 39924893
PMC: 11812354.
DOI: 10.1080/19490976.2025.2464945.
Gupta A, Morella N, Sutormin D, Li N, Gaisser K, Robertson A
bioRxiv. 2025; .
PMID: 39868116
PMC: 11761130.
DOI: 10.1101/2025.01.13.632860.
Kordahi M, Daniel N, Gewirtz A, Chassaing B
Gut Microbes. 2025; 17(1):2455790.
PMID: 39865067
PMC: 11776472.
DOI: 10.1080/19490976.2025.2455790.
Flory M, Bravo P, Alam A
Immunometabolism (Cobham). 2024; 6(4):e00050.
PMID: 39624362
PMC: 11608621.
DOI: 10.1097/IN9.0000000000000050.
Intratumoral microbiota in colorectal cancer: focus on specific distribution and potential mechanisms.
Long J, Wang J, Xiao C, You F, Jiang Y, Li X
Cell Commun Signal. 2024; 22(1):455.
PMID: 39327582
PMC: 11426098.
DOI: 10.1186/s12964-024-01831-3.
Distinct gut microbiomes in Thai patients with colorectal polyps.
Intarajak T, Udomchaiprasertkul W, Khoiri A, Sutheeworapong S, Kusonmano K, Kittichotirat W
World J Gastroenterol. 2024; 30(27):3336-3355.
PMID: 39086748
PMC: 11287419.
DOI: 10.3748/wjg.v30.i27.3336.
Gut Microbiota Signatures in Colorectal Cancer as a Potential Diagnostic Biomarker in the Future: A Systematic Review.
Herlo L, Salcudean A, Sirli R, Iurciuc S, Herlo A, Nelson-Twakor A
Int J Mol Sci. 2024; 25(14).
PMID: 39063179
PMC: 11276678.
DOI: 10.3390/ijms25147937.
Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer.
Li D, Zhong C, Yang M, He L, Chang H, Zhu N
Gut Microbes. 2024; 16(1):2341647.
PMID: 38659246
PMC: 11057575.
DOI: 10.1080/19490976.2024.2341647.
The Hallmarks of Precancer.
Stangis M, Chen Z, Min J, Glass S, Jackson J, Radyk M
Cancer Discov. 2024; 14(4):683-689.
PMID: 38571435
PMC: 11170686.
DOI: 10.1158/2159-8290.CD-23-1550.
The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the NF-κB/HIF-1α Signaling Pathway.
Yao L, Zhai W, Jiang Z, He R, Xie W, Li Y
Anticancer Agents Med Chem. 2024; 24(11):878-888.
PMID: 38571352
DOI: 10.2174/0118715206283884240326170501.
Ginsenoside Rk3 modulates gut microbiota and regulates immune response of group 3 innate lymphoid cells to against colorectal tumorigenesis.
Bai X, Fu R, Liu Y, Deng J, Fei Q, Duan Z
J Pharm Anal. 2024; 14(2):259-275.
PMID: 38464791
PMC: 10921328.
DOI: 10.1016/j.jpha.2023.09.010.
Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer.
Wang B, Zhang S, Wang H, Wang M, Tao Y, Ye M
Cancer Gene Ther. 2024; 31(6):871-883.
PMID: 38459370
DOI: 10.1038/s41417-024-00743-1.
Analysis of differences in intestinal flora associated with different BMI status in colorectal cancer patients.
Huang Y, Huang X, Wang Z, He F, Huang Z, Chen C
J Transl Med. 2024; 22(1):142.
PMID: 38331839
PMC: 10854193.
DOI: 10.1186/s12967-024-04903-7.
Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma.
Takashima Y, Kawamura H, Okadome K, Ugai S, Haruki K, Arima K
Clin Microbiol Infect. 2024; 30(5):630-636.
PMID: 38266708
PMC: 11043012.
DOI: 10.1016/j.cmi.2024.01.013.
Changes of gut microbiota and short chain fatty acids in patients with Peutz-Jeghers syndrome.
Zhou A, Tang B, Xie Y, Li S, Xiao X, Wu L
BMC Microbiol. 2023; 23(1):373.
PMID: 38036954
PMC: 10688050.
DOI: 10.1186/s12866-023-03132-0.
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.
Pandey H, Jain D, Tang D, Wong S, Lal D
Intest Res. 2023; 22(1):15-43.
PMID: 37935653
PMC: 10850697.
DOI: 10.5217/ir.2023.00080.
Association between metabolic syndrome and early-stage colorectal cancer.
Zhang C, Zhang L, Tian Y, Guan B, Li S
BMC Cancer. 2023; 23(1):1020.
PMID: 37872512
PMC: 10591414.
DOI: 10.1186/s12885-023-11537-3.
Dietary D-xylose promotes intestinal health by inducing phage production in Escherichia coli.
Hu J, Wu Y, Kang L, Liu Y, Ye H, Wang R
NPJ Biofilms Microbiomes. 2023; 9(1):79.
PMID: 37821428
PMC: 10567762.
DOI: 10.1038/s41522-023-00445-w.
Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort.
Gong D, Adomako-Bonsu A, Wang M, Li J
PeerJ. 2023; 11:e15777.
PMID: 37554340
PMC: 10405800.
DOI: 10.7717/peerj.15777.